IBio FY 2024 GAAP EPS $(6.50) Beats $(7.41) Estimate, Sales $225.000K Beat $25.000K Estimate
IBio FY 2024 GAAP EPS $(6.50) Beats $(7.41) Estimate, Sales $225.000K Beat $25.000K Estimate
iBio 2024財年GAAP每股收益爲$(6.50)，超出$(7.41)的預估，銷售額爲$22.5萬，超出$2.5萬的預估
iBio (AMEX:IBIO) reported quarterly losses of $(6.50) per share which beat the analyst consensus estimate of $(7.41) by 12.28 percent. The company reported quarterly sales of $225.000 thousand which beat the analyst consensus estimate of $25.000 thousand by 800.00 percent.
iBio (美交所:IBIO)報告每股虧損$(6.50)，超過分析師共識預估的$(7.41) 12.28%。公司報告季度銷售額爲$22.5萬，超過分析師共識預估的$2.5萬 800.00%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。